Master in Medical Biotechnology

At Università degli Studi del Piemonte Orientale, tuition fees are 2,451 EUR per year.

Medical Biotechnology applies the tools of molecular biology, genetics, and biochemistry to problems in human health, covering areas such as diagnostics, drug development, regenerative medicine, and disease mechanisms. Students in this field typically study molecular and cell biology, genetics, immunology, pharmacology, and laboratory techniques used to analyse biological samples, alongside coursework that connects basic biological research to clinical and industrial applications. The discipline sits between fundamental biological science and applied medical research, training students to work with the methods used to develop new diagnostic tools and therapies. Graduates of medical biotechnology programs often work in pharmaceutical and biotechnology companies, diagnostic laboratories, hospitals, and public and private research institutes. Career paths include roles in drug discovery and development, clinical research, quality control, and regulatory affairs, as well as further academic research toward a doctoral degree. Because the field draws on rapidly evolving areas such as genomics and cell-based therapies, professionals trained in medical biotechnology are relevant to both established healthcare industries and newer biotech ventures. This master's degree in Medical Biotechnology is taught in English at Universita degli Studi del Piemonte Orientale, based in Vercelli, Italy, and lasts 2 years. As a second-cycle program, it is intended for students holding a bachelor's degree, typically in biology, biotechnology, or a related life science, who want to deepen their expertise in the biological and clinical mechanisms underlying human disease and its treatment. Vercelli, located in the Piedmont region of northwestern Italy, hosts this English-language program within a university associated with health and life science research in the area.